Related references
Note: Only part of the references are listed.Selenium Administration Attenuates 5-Flurouracil-Induced Intestinal Mucositis
Jae Min Lee et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2017)
Amelioration of Chemotherapy-Induced Intestinal Mucositis by Orally Administered Probiotics in a Mouse Model
Chun-Yan Yeung et al.
PLOS ONE (2015)
Anti-inflammatory role of DPP-4 inhibitors in a nondiabetic model of glomerular injury
Yoshiki Higashijima et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2015)
Inhibition of Caspases Protects Mice from Radiation-induced Oral Mucositis and Abolishes the Cleavage of RNA-binding Protein HuR
Sudha Talwar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
S-Nitrosoglutathione Accelerates Recovery from 5-Fluorouracil-Induced Oral Mucositis
Maria Adriana Skeff et al.
PLOS ONE (2014)
Effect of topical chamomile on immunohistochemical levels of IL-1β and TNF-α in 5-fluorouracil-induced oral mucositis in hamsters
Marina Curra et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Glucagon-like peptide-1 as a treatment for chemotherapy-induced mucositis
Hannelouise Kissow et al.
GUT (2013)
Systematic review of agents for the management of gastrointestinal mucositis in cancer patients
Rachel J. Gibson et al.
SUPPORTIVE CARE IN CANCER (2013)
The effect of glucagon-like peptide 1 on cardiovascular risk
Jacob Sivertsen et al.
NATURE REVIEWS CARDIOLOGY (2012)
The Role of Intestinal Microbiota in the Development and Severity of Chemotherapy-Induced Mucositis
Michel J. van Vliet et al.
PLOS PATHOGENS (2010)
Glucagon-Like Peptide-1 Protects β-Cells Against Apoptosis by Increasing the Activity of an Igf-2/Igf-1 Receptor Autocrine Loop
Marion Cornu et al.
DIABETES (2009)
Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution
Pedro M. G. Soares et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Sitagliptin, a DPP-4 inhibitor for the treatment of patients with type 2 diabetes: a review of recent clinical trials
Avraham Karasik et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Emerging drugs for chemotherapy-induced mucositis
Dorothy M. Keefe et al.
EXPERT OPINION ON EMERGING DRUGS (2008)
VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss
Joanne M. Bowen et al.
CANCER BIOLOGY & THERAPY (2007)
Treatment of mucositis, including new medications
Rajesh V. Lalla et al.
CANCER JOURNAL (2006)
Developing evidence-based guidelines for management of alimentary mucositis: process and pitfalls
Dorothy M. Keefe et al.
SUPPORTIVE CARE IN CANCER (2006)
Rapid quantitative detection of chytridiomycosis (Batrachochytrium dendrobatidis) in amphibian samples using real-time Taqman PCR assay
DG Boyle et al.
DISEASES OF AQUATIC ORGANISMS (2004)
Perspectives on cancer therapy-induced mucosal injury - Pathogenesis, measurement, epidemiology, and consequences for patients
ST Sonis et al.
CANCER (2004)
Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats
L Farilla et al.
ENDOCRINOLOGY (2002)
The short half-life of glucagon-like peptide-1 in plasma does not reflect its long-lasting beneficial effects
HX Hui et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2002)
Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters
ST Sonis et al.
ORAL ONCOLOGY (2000)
Share Paper
